2025
SJR Q2
JCR Q1 · 3,4
OA
78 eşleşen makale
SCIE
Dergi ayrıntısı
Hypertension in Pregnancy
- Yayıncı
- Taylor and Francis Ltd.
- Ülke
- United Kingdom · Western Europe
- Tür
- journal
- ISSN
-
1064195515256065
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 0,736
- Quartile Q2
- H-Index 57
- Atıf/yayın 2,84
- Doküman (3y) 62
- Atıf (3y) 148
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 3,4
- 5Y JIF 1,9
- JCI 0,67
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Internal Medicine Q2
- Obstetrics and Gynecology Q2
Alanlar
- Medicine
WoS kategorileri
- Obstetrics & Gynecology | Physiology | Peripheral Vascular Diseases
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q1 | 0,736 | 3,4 | 1,9 | 0,67 | Q2 | 57 |
| 2024 | Q2 | Q2 | 0,522 | 2,1 | 1,9 | 0,44 | Q3 | 55 |
| 2023 | Q3 | Q3 | 0,442 | 1,5 | 2,1 | 0,47 | Q3 | 55 |
| 2022 | Q2 | Q4 | 0,451 | 1,5 | 2 | 0,49 | Q3 | 55 |
| 2021 | Q3 | Q3 | 0,421 | 2,7 | 2,4 | 0,53 | Q3 | 55 |
| 2020 | Q2 | Q3 | 0,752 | 2,1 | 2,3 | 0,68 | Q2 | 55 |
| 2019 | Q2 | Q3 | 0,64 | 1,8 | 1,8 | 0,57 | Q3 | 55 |
| 2018 | — | Q3 | — | 1,7 | 1,8 | 0,54 | Q3 | — |
| 2017 | Q2 | Q4 | 0,556 | 1,3 | 1,5 | 0,41 | Q3 | 55 |
| 2016 | Q2 | Q4 | 0,55 | 1,1 | 1,5 | — | — | 55 |
| 2015 | Q2 | Q4 | 0,59 | 1,2 | 1,2 | — | — | 55 |
| 2014 | Q2 | Q3 | 0,525 | 1,4 | 1,3 | — | — | 55 |
| 2013 | Q2 | Q4 | 0,667 | 1,2 | 1,5 | — | — | 55 |
| 2012 | Q2 | Q4 | 0,627 | 0,9 | 1,4 | — | — | 55 |
| 2011 | Q2 | Q2 | 0,593 | 1,7 | 1,8 | — | — | 55 |
| 2010 | Q2 | Q3 | 0,367 | 1,5 | 1,4 | — | — | 55 |
| 2009 | — | Q3 | — | 1,4 | 1,5 | — | — | — |
| 2008 | — | Q4 | — | 1,1 | 1,6 | — | — | — |
| 2007 | — | Q3 | — | 1,2 | 1,5 | — | — | — |
| 2006 | — | Q4 | — | 0,9 | — | — | — | — |
| 2005 | — | Q3 | — | 1,5 | — | — | — | — |
| 2004 | — | Q2 | — | 1,4 | — | — | — | — |
| 2003 | — | Q3 | — | 1 | — | — | — | — |
| 2002 | — | Q2 | — | 1,2 | — | — | — | — |
| 2001 | — | Q2 | — | 1,2 | — | — | — | — |
| 2000 | — | Q3 | — | 0,8 | — | — | — | — |
| 1999 | — | Q2 | — | 0,9 | — | — | — | — |
| 1998 | — | Q2 | — | 1 | — | — | — | — |
| 1997 | — | Q2 | — | 1 | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | OBSTETRICS & GYNECOLOGY | SCIE | Q1 | Q3 | 27/143 |
| 2025 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | Q2 | 27/100 |
| 2025 | PHYSIOLOGY | SCIE | Q2 | Q3 | 23/89 |
| 2024 | OBSTETRICS & GYNECOLOGY | SCIE | Q2 | Q3 | 55/141 |
| 2024 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | Q3 | 53/98 |
| 2024 | PHYSIOLOGY | SCIE | Q3 | Q4 | 51/87 |
| 2023 | OBSTETRICS & GYNECOLOGY | SCIE | Q3 | Q3 | 89/136 |
| 2023 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | Q3 | 67/96 |
| 2023 | PHYSIOLOGY | SCIE | Q4 | Q4 | 70/85 |
| 2022 | OBSTETRICS & GYNECOLOGY | SCIE | Q4 | Q3 | 75/85 |
| 2022 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | Q3 | 59/68 |
| 2022 | PHYSIOLOGY | SCIE | Q4 | Q4 | 70/79 |
| 2021 | OBSTETRICS & GYNECOLOGY | SCIE | Q3 | Q3 | 52/85 |
| 2021 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | Q3 | 45/67 |
| 2021 | PHYSIOLOGY | SCIE | Q3 | Q3 | 48/81 |
| 2020 | OBSTETRICS & GYNECOLOGY | SCIE | Q3 | Q3 | 58/83 |
| 2020 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | Q2 | 51/65 |
| 2020 | PHYSIOLOGY | SCIE | Q4 | Q3 | 61/81 |
| 2019 | OBSTETRICS & GYNECOLOGY | SCIE | Q3 | Q3 | 54/82 |
| 2019 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | Q3 | 50/65 |
| 2019 | PHYSIOLOGY | SCIE | Q3 | Q4 | 57/81 |
| 2018 | OBSTETRICS & GYNECOLOGY | SCIE | Q3 | Q3 | 53/83 |
| 2018 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | Q3 | 48/65 |
| 2018 | PHYSIOLOGY | SCIE | Q4 | Q4 | 61/81 |
| 2017 | OBSTETRICS & GYNECOLOGY | SCIE | Q4 | Q3 | 69/82 |
| 2017 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | Q3 | 56/65 |
| 2017 | PHYSIOLOGY | SCIE | Q4 | Q4 | 72/83 |
| 2016 | OBSTETRICS & GYNECOLOGY | SCIE | Q4 | — | 69/80 |
| 2016 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 60/63 |
| 2016 | PHYSIOLOGY | SCIE | Q4 | — | 74/84 |
| 2015 | OBSTETRICS & GYNECOLOGY | SCIE | Q4 | — | 64/80 |
| 2015 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 55/63 |
| 2015 | PHYSIOLOGY | SCIE | Q4 | — | 73/83 |
| 2014 | OBSTETRICS & GYNECOLOGY | SCIE | Q3 | — | 55/79 |
| 2014 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 51/60 |
| 2014 | PHYSIOLOGY | SCIE | Q4 | — | 67/83 |
| 2013 | OBSTETRICS & GYNECOLOGY | SCIE | Q4 | — | 62/78 |
| 2013 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 54/65 |
| 2013 | PHYSIOLOGY | SCIE | Q4 | — | 70/81 |
| 2012 | OBSTETRICS & GYNECOLOGY | SCIE | Q4 | — | 63/78 |
| 2012 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 58/68 |
| 2012 | PHYSIOLOGY | SCIE | Q4 | — | 67/80 |
| 2011 | OBSTETRICS & GYNECOLOGY | SCIE | Q2 | — | 38/79 |
| 2011 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 42/68 |
| 2011 | PHYSIOLOGY | SCIE | Q3 | — | 56/79 |
| 2010 | OBSTETRICS & GYNECOLOGY | SCIE | Q3 | — | 44/77 |
| 2010 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 44/68 |
| 2010 | PHYSIOLOGY | SCIE | Q3 | — | 57/78 |
| 2009 | OBSTETRICS & GYNECOLOGY | SCIE | Q3 | — | 42/70 |
| 2009 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 43/61 |
| 2009 | PHYSIOLOGY | SCIE | Q4 | — | 59/75 |
| 2008 | OBSTETRICS & GYNECOLOGY | SCIE | Q4 | — | 49/61 |
| 2008 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 46/56 |
| 2008 | PHYSIOLOGY | SCIE | Q4 | — | 62/74 |
| 2007 | OBSTETRICS & GYNECOLOGY | SCIE | Q3 | — | 38/60 |
| 2007 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 40/54 |
| 2007 | PHYSIOLOGY | SCIE | Q3 | — | 58/78 |
| 2006 | OBSTETRICS & GYNECOLOGY | SCIE | Q4 | — | 47/59 |
| 2006 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 45/52 |
| 2006 | PHYSIOLOGY | SCIE | Q4 | — | 65/78 |
| 2005 | OBSTETRICS & GYNECOLOGY | SCIE | Q3 | — | 29/57 |
| 2005 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 33/51 |
| 2005 | PHYSIOLOGY | SCIE | Q3 | — | 53/75 |
| 2004 | OBSTETRICS & GYNECOLOGY | SCIE | Q2 | — | 25/55 |
| 2004 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 33/51 |
| 2004 | PHYSIOLOGY | SCIE | Q3 | — | 48/74 |
| 2003 | OBSTETRICS & GYNECOLOGY | SCIE | Q3 | — | 31/53 |
| 2003 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 36/52 |
| 2003 | PHYSIOLOGY | SCIE | Q4 | — | 57/74 |
| 2002 | OBSTETRICS & GYNECOLOGY | SCIE | Q2 | — | 25/52 |
| 2002 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 31/52 |
| 2002 | PHYSIOLOGY | SCIE | Q3 | — | 50/73 |
| 2001 | OBSTETRICS & GYNECOLOGY | SCIE | Q2 | — | 21/52 |
| 2001 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 31/50 |
| 2001 | PHYSIOLOGY | SCIE | Q3 | — | 48/74 |
| 2000 | OBSTETRICS & GYNECOLOGY | SCIE | Q3 | — | 34/57 |
| 2000 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 34/45 |
| 2000 | PHYSIOLOGY | SCIE | Q4 | — | 64/76 |
| 1999 | OBSTETRICS & GYNECOLOGY | SCIE | Q2 | — | 22/56 |
| 1999 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 30/44 |
| 1999 | PHYSIOLOGY | SCIE | Q3 | — | 50/74 |
| 1998 | OBSTETRICS & GYNECOLOGY | SCIE | Q2 | — | 26/53 |
| 1998 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 22/39 |
| 1998 | PHYSIOLOGY | SCIE | Q3 | — | 38/67 |
| 1997 | OBSTETRICS & GYNECOLOGY | SCIE | Q2 | — | 18/54 |
| 1997 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 21/38 |
| 1997 | PHYSIOLOGY | SCIE | Q3 | — | 34/65 |